DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Koh C, Surana P, Han T. et al.
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study.
Journal Of Hepatology 2017;
66: S101-S102
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.